. A training set with 231 samples (80% of 1 4 4 total samples) was selected and the remaining data corresponding to 58 samples (20% of total 1 4 5 samples) was left as the test set. Missing values in the training and test sets were replaced by 1 4 6 corresponding median value in the training set. The RF classifier was implemented using a 3-1 4 7
fold (stratified) cross validation and was trained using all 65 immune profile features, the 40 1 4 8 significantly different features, the top 10 significantly different features and the top 10 features 1 4 9 among the 40 significantly different features that received the highest importance score. 1 5 0 1 5 1
There are several metrics to evaluate the performance of a classifier. Sensitivity represents the 1 5 2 proportion of patients who were correctly identified as patients and specificity represents the 1 5 3
proportion of healthy controls who were correctly identified as healthy. If patients are denoted by 1 5 4
"positives" and healthy controls by "negatives", then sensitivity and specificity are calculated as:
1 5 8 where "true positives" refer to patients who were correctly identified as patients and "true 1 5 9
negatives" refer to healthy controls who were correctly identified as healthy.
Accuracy is a metric which shows the fraction of predictions that our classifier predicted 1 6 1 correctly. Accuracy is calculated in terms of true positives and true negatives as: Remarkably, ME/CFS subjects, compared to controls, displayed lower expression of IL-17+ 2 7 7 (p=0.0035), IL-17+IFNγ+ (p=0.0055), and IL-17+IFNγ-(p=0.0084), but not total IFNγ+ (p=0.3), 2 7 8 within the CD4+CD45RO+CCR6+ T cells (Fig. 4c) . After 6 days in culture in IL-7, the 2 7 9 differences further increased and were seen in all cytokine-secreting cells, as a proportion of 2 8 0 CD4+CD45RO+CCR6+ T cells, for IL-17+ (p<0.0001), IFNγ+ (p=0.0010), IL-17+IFNγ+ 2 8 1 (p<0.0001), and IL-17+IFNγ-(p<0.0001) cells (Fig. 4d ) .  2  8  2  2  8  3 We next determined the ratio between the CCR6+ T cells to CD4+ memory T cells expressing 2 8 4 IL-17 or IFNγ. Indeed, the ratio of CCR6+ cells to IL-17+ (p<0.0001) and to IFNγ+ (p<0.0001) 2 8 5 CD4+ memory T cells were significant in ME/CFS patients compared to healthy controls (Fig.  2  8  6 4e). These ratios between CCR6+ cells and cytokines produced by CD4+ cells also remained 2 8 7 higher in ME/CFS subjects after d6 in IL-7, for CCR6+ to IL-17+ cell ratio (p=0.0015), but were 2 8 8 only marginally different for CCR6+ to IFNγ+ cell ratio (p=0.0366) (Fig. 4f ). 2 8 9 2 9 0
We have previously shown that CD161 within the CD4+CD45RO+CCR6+ T cells can further 2 9 1 divide these cells into subsets with differences in IL-17 and IFNγ secretion (Wan et al., 2011) .
As such, we further divided CCR6+ cells based on CD161 expression (Fig. 5a ). The proportion 2 9 3 of CD161+ cells within the CCR6+ subset was only slightly different in ME/CFS compared to 2 9 4 controls (p=0.0439) (Fig. 5a ). We then analyzed IL-17 and IFNγ expression within the CD161+ 2 9 5 and CD161-subsets of CD4+ CD45RO+ CCR6+ cells after 6 days in culture (Fig. 5b) . Within 2 9 6 the CD4+CCR6+CD161+ cells, there was a significant difference in expression of IL-17+, IL-2 9 7 17+IFNγ+, and IL-17+IFNγ-cells between ME/CFS and controls (p<0.0001 for all), but not for 2 9 8 IL-17-IFNγ+ cells (p=0.06) (Fig. 5c ). CD161-cells within the CD4+CD45RO+CCR6+ subset 2 9 9 also displayed lower IL-17+, IL-17+IFNγ+, IL-17+IFNγ-, and IL-17-IFNγ+ in ME/CFS subjects 3 0 0 compared to healthy controls (p=<0.0001, <0.0001, 0.0001, and 0.0042, respectively), (Fig. 5d ). 3 0 1 3 0 2
In CD4+ memory T cells, in addition to IL-17 expression, we also determined the frequency of T 3 0 3 cells that were either expressing IFNγ (IFNγ+IL-4-) or IL-4 (IFNγ-IL-4+) only, which 3 0 4 respectively define Th1 and Th2 T cell subsets (Fig. 5e ). We found that the proportion of 3 0 5
IFNγ+IL-4-and IFNγ-IL-4+ within CD4+ memory T cells was significantly lower (p=0.0157 3 0 6 and p<0.0001 respectively) in ME/CFS subjects (Fig. 5e) . However, the ratio of Th1 (IFNγ+IL-3 0 7 4-) to Th2 (IFNγ-IL-4+) was higher in ME/CFS patients compared to the control group 3 0 8 (p=0.0196) (Fig. 5b) , suggesting an imbalance of Th1 to Th2 cells. Together, these findings 3 0 9 highlight major functional perturbations within the CD4+ T cell subset in the ME/CFS patient 3 1 0 cohort.
Changes in Frequency of MAIT cells in ME/CFS 3 1 3 3 1 4
Mucosal-associated invariant T (MAIT) cells are a subset of the non-classical T cell population 3 1 5
and defined by an invariant T cell receptor that is triggered by riboflavin metabolites produced 3 1 6 by bacteria, including commensal microbiota (Tastan et al., 2018; Godfrey et al., 2019 and CD4-CD8-(double negative or DN) T cell compartments in ME/CFS patients and healthy 3 2 2 controls ( Fig. 6a ). There was no significant difference between patients and controls for CD4+ 3 2 3 (p=0.7), CD8+ (p=0.7), or double negative (DN) MAIT cells (p=0.2) as a proportion of the 3 2 4 CD4+, CD8+ and DN T cells respectively (Fig. 6b ). However, CD4+ and CD8+ MAIT cell 3 2 5 frequencies in PBMC after 6-day culture in IL-7 showed a significant difference (p=0.0250 and 3 2 6 p=0.0221 respectively) between ME/CFS patients and controls, but DN MAIT cell frequency did 3 2 7 not change between ME/CFS and control samples after 6 days culture (p=0.3) (Fig. 6c ). When 3 2 8 the ratio of MAIT cell frequency at day 0 (d0) vs day 6 after IL-7 culture (d6) was assessed, we 3 2 9
found that the frequency of CD8+ MAIT cells in ME/CFS PBMC was greatly reduced after 6 3 3 0 days of culture compared to d0 levels (p=0.0008), but there was no significant difference seen 3 3 1 for CD4+ (p=0.06) or for DN MAIT cells (p=0.8) between ME/CFS patients and controls (Fig.  3  3  2 6d). Corollary to this finding, the ratio of CD8+ MAIT to DN MAIT cells in ME/CFS patients 3 3 3 and controls was only slightly significant at d0 (p=0.0364), but became highly significant after 6 3 3 4 days in culture with IL-7 (p<0.0001) (Fig. 6e ). Together, these findings suggest that CD8+ 3 3 5
MAIT cells from ME/CFS subjects survived less in in vitro culture with IL-7. 3 3 6 3 3 7
Because CD27 expression on MAIT cells could indicate a recently activated or differentiated 3 3 8 subset, similar to other CD8 T cells (Dolfi and Katsikis, 2007; Grant et al., 2017) , we evaluated 3 3 9 CD27 expression in MAIT subsets (Fig. 6f ). We found that ME/CFS patients had a significant 3 4 0 difference where there were higher CD45RO+CD27-cells compared to the control group 3 4 1 (p=0.0045), but interestingly, this difference was not observed within DN MAIT cells (p=0.7) 3 4 2 (Fig. 6g) . The d0 to d6 CD8+ MAIT cell ratio also displayed a slight positive correlation with the We then asked to what extent MAIT cells were functionally different between ME/CFS patients 3 4 8 and controls. For this approach we first stimulated the PBMC with a cocktail of three cytokines, 3 4 9 namely IL-12+IL-15+IL18, since this combination has been uniquely shown to induce 3The ratio of Th17 cells to Tregs is an important feature that is perturbed during chronic 4 0 1 inflammatory conditions or autoimmune diseases. Therefore, we also determined this ratio in 4 0 2 ME/CFS patients vs healthy controls. While the Th17 (CCR6+ IL-17-secreting cells) frequency 4 0 3 did not correlate with memory Treg cells in ME/CFS patients ‫ݎ(‬ ௦ =0.2750) or healthy controls 4 0 4 ‫ݎ(‬ ௦ =-0.08416), remarkably, the ratio of these two related subsets were also highly different 4 0 5 between the ME/CFS patients and the healthy controls (p<0.0001) (Fig. 8e ) 4 0 6 4 0 7
Machine learning analysis to identify predictive immune parameters for ME/CFS 4 0 8 4 0 9
Our immune profiling analysis identified many T cell subset parameters that were different in 4 1 0 ME/CFS patients vs healthy controls. From the total of 65 immune profile features, 40 features 4 1 1 were identified as different at a 5% false discovery rate (Supplemental Table 2 ). However, while 4 1 2 some of these were highly significant, given the high variability and ranges in humans for 4 1 3 immune parameters, on their own they would not have clinically relevant specificity and 4 1 4 sensitivity to discriminate patients from healthy individuals. Therefore, we decided to use a 4 1 5 classifier model using a machine learning algorithm called the random forest (RF) classifier 4 1 6 (Wang and Li, 2017).
The RF classifier or algorithm is an ensemble method that depends on a large number of 4 1 9 individual classification trees (Wang and Li, 2017;Huynh-Thu and Geurts, 2019). Each 4 2 0 classification tree emits a predicted class and the class with the most votes becomes the model 4 2 1 prediction. The individual trees are designed using a randomly selected number of samples 4 2 2 (sampling with replacement) and a randomly selected feature set to minimize correlation 4 2 3 between trees. A large number of relatively uncorrelated classification trees (models) are 4 2 4 combined to provide a robust classification of the individual sample (Aevermann et al., 2018). 4 2 5
As such, we implemented an RF model to classify ME/CFS patients and healthy controls using 4 2 6 the immune profiling data. The performance of the RF was evaluated using the receiver 4 2 7 operating characteristic (ROC) curve, which is created by plotting the true positive rate (TPR) 4 2 8 against the false positive rate (FPR). The class prediction probability of a sample can be 4 2 9 computed based on the proportion of votes obtained for that call. Given a threshold T for the 4 3 0 probability, a sample is classified as an ME/CFS patient if the probability is higher than T and 4 3 1 the ROC curve plots TPR against the FPR. 4 3 2 4 3 3
The area under the ROC curve which is denoted by AUC is equal to the probability that a 4 3 4 randomly chosen positive instance will be ranked higher than a randomly chosen negative 4 3 5 instance. A perfect classifier will have the maximal area under the curve of 1. The ROC curves 4 3 6 of the RF classifier corresponding to 4 subsets of immune profile features are shown in Figure 9 . 4 3 7
The AUC of the RF classifier using all 65 features is ~0.93, meaning that there is a chance of 93% 4 3 8 that the classifier will correctly distinguish between patients and healthy controls ( Fig. 9 and 4 3 9 Fletcher et al., 2010; Brenu et al., 2012; Curriu et al., 2013; Brenu et al., 2014) . Here we extend 4 4 9 these findings and show a highly significant disruption in several key T cell subset frequencies, 4 5 0 and importantly, their effector functions. Our findings reveal profound changes in the functional 4 5 1 capacity of mucosal associated T cell (MAIT) and Th17 cells, Tregs, and signs of CD8+ T cell 4 5 2 and NK cell disruption in a subset of younger subjects. Given that these cell types are involved in 4 5 3 regulating viral or bacterial infections or the microbiota, our findings suggest that some of the 4 5 4 ME/CFS patients have severe immune perturbations likely triggered by chronic infections or are 4 5 5 associated with changes in the microbiome. 4 5 6 4 5 7
Our observation that both CD8+ T cells and NK cells are proportionately reduced in ME/CFS 4 5 8 subjects may also reflect chronic viral infection or persistence (such as CMV or EBV infections) 4 5 9 that triggers a chronic activated state of these cells. It is important to note that this difference was 4 6 0 predominantly observed in subjects younger than 50 years old, as healthy subjects over the age 4 6 1 of 50 also begin to display a similar phenotype as patients and thus were no longer statistically 4 6 2 different compared to patient subjects. Indeed, this is consistent with the increase in chronic viral 4 6 3 infections seen during normal aging, such as CMV seropositivity (Ellefsen et al., 2002) .
However, given this distribution, these subset differences alone are unlikely to be the main cause 4 6 5 of ME/CFS symptoms as it is apparent there are also multiple and severe changes in the effector 4 6 6 functions of other T cell subsets. In addition, the proportion of CMV/EBV infection among 4 6 7 healthy controls and ME/CFS patients was not significantly different in either age group (data 4 6 8 not shown). 4 6 9 4 7 0
Another T cell subset that we found to be highly disrupted in ME/CFS subjects was Th17 cells, 4 7 1 which are characterized by secretion of IL-17, expression of chemokine receptor CCR6 and 4 7 2 transcription factor RORC (Sallusto et al., 2012) . Th17 cells play a major role in both immune 4 7 3 response to bacterial or fungal infections and in pathogenesis of autoimmune or chronic 4 7 4 inflammatory diseases (Tesmer et al., 2008; Sallusto and Lanzavecchia, 2009 ). We previously 4 7 5
found that a significant portion of cells programmed towards the Th17 phenotype do not 4 7 6 immediately secrete IL-17 but require a priming stage with IL-7 or IL-15, which we call poised 4 7 7
Th17 cells (Wan et al., 2011) . Indeed, when we performed an assay by culturing PBMC in IL-7 4 7 8 for 6 days before analyzing the IL-17 production from these poised CCR6+ Th17 cells, the 4 7 9 differences between ME/CFS patients and controls became profound. However, while there were 4 8 0 less Th17 cells producing IL-17 in ME/CFS patients, paradoxically the proportion of CCR6+ 4 8 1 Th17 cells were significantly higher compared to controls. Together these findings suggest 4 8 2 chronic activation of the Th17 subset that potentially induces an "exhausted" state, as when their 4 8 3 numbers are increased due to chronic stimulation, they become more dysfunctional. One possible 4 8 4 culprit for chronic Th17 cell stimulation could be the changes in the composition of microbiota, 4 8 5 or dysbiosis that is caused by shifting balances in beneficial or harmful bacteria species 4 8 6 (Omenetti and Pizarro, 2015), as seen during HIV infection (Lujan et al., 2019) , and as 4 8 7 contributes to autoimmune diseases (Gulden et al., 2015) . There is also evidence that Th17 cells 4 8 8 can respond to specific microbiota-associated bacteria such as Prevotella species (Larsen, 2017) . are increased in ME/CFS patients is consistent with our other findings that there appears to be a 4 9 6 chronic activation of major T cell subsets with yet to be identified stimuli. Increased Tregs in 4 9 7 patients may reflect the disturbance of the Th17 and Th1/Th2 cytokine balance in ME/CFS 4 9 8 patients, suggesting a major disruption in homeostatic maintenance of immune responses. 4 9 9
Indeed, for example, the balance between Th17 cells and Tregs is also critical in the regulation of 5 0 0 inflammation, especially related to the gut and microbiome (Omenetti and Pizarro, 5 0 1 2015; Pandiyan et al., 2019) . Remarkably, we found a correlation between Th17 and Treg cells in 5 0 2 ME/CFS patients, and found the ratio was even more significantly different in patients compared 5 0 3 to controls. These findings reveal potential biomarkers that can be utilized in future clinical 5 0 4
interventions to re-balance the microbiome and the mucosal immune responses. In future studies 5 0 5 it will also be important to further investigate in more detail the different subsets of Tregs for 5 0 6 their suppressive capacity, and as with other subsets, to identify the mechanisms that lead to their 5 0 7 increase in ME/CFS patients. 5 0 8 5 0 9
In our analysis, another T cell subset that was profoundly different between patients and controls, severe ME/CFS patients (Cliff et al., 2019). We did not observe significant changes in the 5 1 5 frequency of MAIT cells as a percentage of PBMC or T cells, which could be due to fact that this 5 1 6 T cell subset is highly variable and has up to a 40-fold difference in range, even among healthy 5 1 7
humans (Ben Youssef et al., 2018) , and that most of our patient group was not characterized as 5 1 8
severe. However, we observed profound differences in MAIT cell functions and differentiated 5 1 9
states in ME/CFS subjects, such as reduced production of cytokines (IFNγ, IL-17) or cytotoxic 5 2 0 molecule GranzymeA, and an increased proportion of CD27 negative CD8+ MAIT cells, which 5 2 1 correlated with their lower survival in 6 day culture with IL-7 in vitro. Given that MAIT cells are 5 2 2 specifically activated by a bacteria-produced riboflavin (vitamin B2) metabolite, we reason that 5 2 3 this perturbation in MAIT cells can also be associated with differences in the composition of the 5 2 4 microbiota of the patients. Indeed, we recently showed that MAIT cells can respond to a variety 5 2 5 of microbiome-related bacteria (Tastan et al., 2018) and that they potentially function to tune or 5 2 6 sense the microbial ecosystem throughout mucosal tissues. Two recent papers also show that 5 2 7
MAIT cell development and expansion is also directly dependent on the microbiome 5 2 8
( Constantinides et al., 2019; Legoux et al., 2019; Oh and Unutmaz, 2019) . In one paper, the 5 2 9
authors show that CD4-CD8-(double negative, or DN) MAIT cells are a functionally distinct 5 3 0 subset that migrate to the skin in mice and are potentially involved in tissue repair (Dias et al., 5 3 1 2018; Constantinides et al., 2019; Oh and Unutmaz, 2019) . Thus, it is interesting to note that we 5 3 2 observed differences in CD8+ but not in DN MAIT cells in ME/CFS subjects, suggesting that 5 3 3 these are different lineages or subsets. Taken together, it is conceivable that a disruption in the 5 3 4 microbiome results in chronic activation of MAIT cells and an exhausted state in ME/CFS 5 3 5 patients, which is similar to what has been seen with the Th17 subset (Cliff et al., 2019) . 5 3 6 5 3 7
Finally, using immune parameters as features, our machine learning classifier was able to 5 3 8 identify the ME/CFS patients at a high sensitivity and accuracy when using all 65 features, all 40 5 3 9
significantly different features and the 10 features among the 40 significantly different features 5 4 0 that had the highest importance score. For all cases, we observed a higher value of sensitivity 5 4 1 than specificity, indicating that the proportion of patients identified as ME/CFS patients is higher 5 4 2 than healthy controls who are correctly identified as healthy. 
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